The pace of scientific discovery is no longer governed solely by the physical limits of manual experimentation. We are currently witnessing a shift that is as transformative as the invention of the microscope itself. Artificial Intelligence (AI) and advanced metabolomics are reshaping how science is conducted, moving research from a “trial-and-error” model to a predictive, data-driven discipline. By combining high-resolution analytical hardware with machine learning, laboratories can now solve complex biological challenges – such as developing animal-free culture media – with unprecedented speed.

The complexity of the modern workflow

In the fast-evolving landscape of biopharmaceuticals and cell biology, the reliance on traditional methods often leads to significant hurdles. For decades, the industry has relied on fetal bovine serum (FBS) to supplement cell culture media, despite its high costs, ethical concerns, and inherent inconsistency.

Many lab teams find themselves buried under mountains of raw data from complex matrices, struggling to identify which specific molecular components actually drive performance.

When dealing with undefined raw ingredients, such as plant and microbial extracts, understanding chemical composition is critical to ensuring batch-to-batch reproducibility and process continuity when scaling.

From raw peaks to actionable insights

The challenge in modern labs isn’t a lack of data; it is the complexity of interpreting high-dimensional datasets. Manual analysis of thousands of formulations is no longer feasible. As regulatory requirements for biologics become more stringent, the demand for defined, reproducible, and regulatory-compliant media has grown.

Advanced metabolomics provides the molecular profiling required to qualify raw materials, while AI handles the broad combinatorial screening. This synergy allows researchers to tailor media composition to specific cell lines, improving yield and efficiency across the drug development lifecycle.

Why Analytical Testing Matters in Biopharma

Biopharmaceutical products, including monoclonal antibodies, cell and gene therapies, and vaccines, are inherently complex. Unlike traditional small-molecule drugs, these products are often derived from living cells, making them highly sensitive to variations in manufacturing and storage conditions.

Analytical testing ensures the quality, purity, potency, and stability of biopharmaceuticals throughout their lifecycle, from early development to final product release.

Without rigorous testing, even minor inconsistencies in a product can lead to reduced efficacy, compromised safety, or regulatory non-compliance. By employing advanced analytical methods, biopharma companies can identify impurities, confirm molecular structures, and monitor critical quality attributes (CQAs) that are essential for maintaining product integrity.

📚 Download The Journey to Biopharma infographic to discover streamlined automation and cutting-edge analytics >

Driving excellence in Analytical Testing

Chemetrix is at the forefront of supporting biopharma companies with advanced analytical solutions. By offering cutting-edge instruments and technologies, we help laboratories address the challenges of testing biologics and other complex products.

We provide access to industry-leading platforms, including HPLC systems, LC-MS, and next-generation spectroscopy tools. These technologies are designed to deliver high sensitivity and precision, ensuring that every aspect of a biopharmaceutical product is rigorously tested.

The new generation Agilent 1260 Infinity III is a robust instrument that delivers the performance, reliability, and robustness you need for the highest confidence in daily HPLC results. With the freedom to mix and match new modules with existing HPLC instrumentation, it’s possible to maximise uptime and minimise disruption while also getting on the fast track to efficiency, optimizing speed and resolution for analysis.

Moreover, Chemetrix offers comprehensive support services, from installation and training to ongoing maintenance and technical assistance. This ensures that labs can maximise the performance of their analytical equipment and stay ahead of industry demands.

📚 Download the Mass Spectrometry of Macromolecules Using Standard Flow LC/MS application note to discover a robust and sensitive LC/MS method using standard LC flow for the analysis of native protein analysis >

The importance of analytical testing in biopharma cannot be overstated. As the industry continues to evolve, the need for advanced testing methods will only grow. By leveraging state-of-the-art technologies and partnering with trusted providers like Chemetrix, biopharma companies can ensure the safety, efficacy, and quality of their products while meeting regulatory expectations. With our commitment to innovation and excellence, Chemetrix stands as a trusted ally for laboratories navigating the complexities of biopharma analytical testing.

With biopharma continuing to grow, there are challenges that naturally arise as part of the sector’s evolution. Here, we explain how Agilent’s products address customer pain points including poor reproducibility and difficulties with instrumentation and methods, with insights from Padraig McDonnell, executive vice president and general manager for the Chemistries and Supplies Division at Agilent Technologies.

The complexity of biopharma development

The complex heterogeneous nature of biotherapeutics requires accurate and robust analytical testing methodologies with dependable chromatographic separations. Identifying critical quality attributes (i.e., impurities that could impact the product safety and efficacy) is the most difficult step in the implementation of a Quality by Design approach for biopharmaceutical development and production. Defining each product attribute is extremely challenging. Therefore, consistency of product quality becomes even more important.

Download the brochure on Solutions for Biopharmaceutical Critical Quality Attributes >

Some of the key challenges in biopharma development are accuracy, robustness, and reproducibility of the data. It all comes down to speed and efficiency of the workflow. It is important to recognise that several analytical techniques are used as part of a workflow solution. This includes sample preparation, separation detection, and data analysis. Each part of the workflow must work seamlessly with the other components to ensure trusted answers.

Watch the webinar on Laboratory Workflow Solutions: What to expect when you’re away from the lab? >

Innovative solutions for quality challenges

Reproducibility is a cornerstone of scientific research, ensuring that results can be consistently replicated to validate findings and advance knowledge. Several factors contribute to this issue, including variability in biological samples, inconsistencies in experimental procedures, and limitations in analytical techniques. Known for their precision and sensitivity, Agilent’s mass spectrometry systems deliver highly reproducible results, essential for accurate biomolecule analysis.

Liquid chromatography is another critical technique in the biopharma and biotherapeutics industries, used extensively for the separation, identification, and quantification of complex biological samples. However, achieving consistent and reproducible results can be challenging due to the complexity and variability of these samples.

Agilent offers a wide range of high-performance LC columns tailored for different applications, ensuring optimal separation of complex biomolecules. These columns are designed to provide high resolution and reproducibility, crucial for accurate quantification.

The systems are equipped with highly sensitive detectors, such as UV, PDA, fluorescence, and mass spectrometry detectors. These detectors provide accurate quantification and detection of analytes at low concentrations, enhancing reproducibility.

Getting the workflow right

With great instruments comes great software. Agilent’s data analysis software integrates seamlessly with their instruments, offering powerful tools for data processing, visualisation, and interpretation. This integration helps ensure that data is accurately analysed and reproducible. These software solutions are designed to maintain data integrity and comply with regulatory standards, supporting reproducibility and reliability in research and development.

Download the brochure on Solutions for Biopharmaceutical Critical Quality Attributes >

Regular customer contact and integrating the voice of customer is really critical to us. It gives us exceptional insight into the scientific challenges our customers face. These insights enable Agilent to put an intentional focus on biopharma, as we continue to develop new products and services that help our customers. Collaboration and cross-functional teamwork have enabled us to deliver new products and workflow solutions that better address customer analytical needs.

The biopharma and biotherapeutics industries face significant challenges related to reproducibility and instrumentation. Chemetrix can assist labs in addressing these pain points with innovative products from Agilent Technologies and comprehensive support, enhancing reproducibility, simplifying instrument operation, and ensuring reliable results. By leveraging advanced analytical instruments solutions, biopharma and biotherapeutics professionals can overcome these challenges, accelerating their research and development efforts and ultimately contributing to the advancement of healthcare.

This article includes information and text originally published by Agilent Technologies

Register to access a diverse lineup of speakers and sessions, including:

• Collaborating in the fight against COVID-19
• A next-generation tool bench for virology research
• Keynote presentation: Viral hijacking of cellular metabolism
• Seahorse XF reveals bioenergetic impact in virology
• Rapid functional evaluation of virus-neutralizing antibodies and antiviral drugs using multiparametric live-cell analysis
• Focus on virology: Applications to enable discovery
• SLIMS: Easier and faster LIMS deployment for COVID
• Faster in, faster out: Achieve the most efficient analysis of raw material for vaccine production
• Agilent BioMDS solutions for vaccine research
• Agilent GC solution for alcohol-based hand sanitizer testing
• Analysis of alcohol levels in hand sanitizer formulations using Cary 630 FTIR
• QA/QC of protection masks

Agenda

Register Here >